Despoina Papazoglou

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Remodeling of the bone marrow vasculature induced by venetoclax and azacitidine damage.

Remodeling of the bone marrow vasculature induced by venetoclax and azacitidine damage.

Journal: Blood

Published: June 02, 2025

Remodelling of the bone marrow vasculature induced by venetoclax and azacitidine damage.

Remodelling of the bone marrow vasculature induced by venetoclax and azacitidine damage.

Journal: Blood

Published: June 02, 2025

Tumor-Infiltrating Clonal Hematopoiesis.

Tumor-Infiltrating Clonal Hematopoiesis.

Journal: The New England journal of medicine

Published: April 23, 2025

Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny.

Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny.

Journal: Blood cancer discovery

Published: February 11, 2025

Clonal hematopoiesis landscape in frequent blood donors.

Clonal hematopoiesis landscape in frequent blood donors.

Journal: Blood

Published: December 09, 2024

Mesenchymal stromal cells from JAK2 V617F myeloproliferative neoplasms support healthy and malignant hematopoiesis in a humanized scaffold model in vivo.

Mesenchymal stromal cells from JAK2 V617F myeloproliferative neoplasms support healthy and malignant hematopoiesis in a humanized scaffold model in vivo.

Journal: HemaSphere

Published: November 15, 2024

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial.

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial.

Journal: Blood

Published: March 23, 2023

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma.

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma.

Journal: The Journal of clinical investigation

Published: November 08, 2022

Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils.

Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils.

Journal: Cell stem cell

Published: October 28, 2022

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.

Journal: Haematologica

Published: October 10, 2022

Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.

Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.

Journal: Frontiers in oncology

Published: November 06, 2020

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy.

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy.

Journal: Blood

Published: March 31, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026